Neuroimaging in glioma therapy

References

• Selker RG, Shapiro WR, Burger P et al. The Brain Tumor Co-operative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy and carmustine. Neurosurgety51, 343–347 (2002).
   PubMed Web of Science ®Google Scholar
• Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann. Neural. 31,431–436 (1992).
   Google Scholar
• Recht LD, Bernstein M. Low-grade gliomas. Neurologic Gun. 13,847–859 (1995).
   Google Scholar
• Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. Histopathology, classification and grading of gliomas. Clia 15,211–221 (1995).
   Google Scholar
• Tortosa A, Ino Y, Odell N, Swilley W, Louis DN, Henson JW. Molecular Genetics of radiographically-defined de nova GBM. Neuropathol App. Neurobial 26,544–552 (2000).
   PubMed Web of Science ®Google Scholar
• Biemat W Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H. Alteration of cell cycle regulatory genes in primary (de nova) and secondary glioblastomas. Acta Neumpath. 94,303–309 (1997).
   PubMedGoogle Scholar
• ••Finds a correlation between the clinicalpresentation and genetic subtypes in patients with glioblastoma.
   Google Scholar
• Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL, Louis DN. Selection pressures of TP53 mutation and microenvironmental location influence number pidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res. 63,413–416 (2003).
   PubMed Web of Science ®Google Scholar
• Agosti RM, Leuthold M, Gullick WJ, Yasargil MG, Wiestler OD. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Virchows Arch. Pathol Anat. 420, 321–325 (1992).
   Google Scholar
• Watanabe K, Tachibana 0, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6, 217–224 (1996).
   Google Scholar
• Reifenberger J, Ring GU, Gies U et al Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. I Neuropathol Exp. Neural. 55,822-831 (1996).
   Google Scholar
• Ohgaki H, Schauble B, zur Hausen A, von Ammon K, Kleihues P. Genetic alterations associated with the evolution and progression of astrocytic brain tumors. Virchows krh. 427, 113–118 (1995).
   Google Scholar
• Shafqat S, Hedley-Whyte ET, Henson JW. Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology52, 867–869 (1999).
   PubMed Web of Science ®Google Scholar
• •Finds a relationship between age at diagnosis and decreasing interval to progression in patients with low-grade astrocytomas.
   Google Scholar
• James CD, Carlblom E, Dumanski JP et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 48, 5546–5551 (1988).
   PubMed Web of Science ®Google Scholar
• Mandonnet E, Delattre JY, Tanguy ML et al Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann. Neural. 53, 524–528 (2003).
   PubMed Web of Science ®Google Scholar
• ••First paper to show that low-grade gliomasactually exhibit gradual growth that can be detected on serial neuorimaging studies taken over long intervals.
   Google Scholar
• Batchelor T, Stanley K, Andersen J. Clinical trials in neuro-oncology. C1.117: Opin. Neural. 14, 689–694 (2001).
   Google Scholar
• Macdonald DR, Cascino TL, Schold SC, Caimcross JG. Response criteria for Phase II studies of malignant glioma. j Clin. Oncol 8, 1277–1280 (1990).
   PubMed Web of Science ®Google Scholar
• Prados MD, Seiferheld W, Sandler HM et al Phase III randomized study of radiotherapy plus procarbazine, lomustine and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int. .1. Radiat. Oncol Biol. Phys. 58, 1147–1152 (2004).
   Google Scholar
• ••Demonstrated a relationship between radiographically determined duration of stable disease and survival in patients with anaplastic astrocytoma.
   Google Scholar
• Caimcross JG, Ueki K, Zlatescu MC et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. j Natl Cancer Instit. 90, 1473–1479 (1998).
   PubMedGoogle Scholar
• Grant R, Liang BC, Slattery J, Greenberg HS, Junck L. Chemotherapy response criteria in malignant glioma. Neurology 48, 1336–1340 (1997).
   Google Scholar
• Sorensen AG, Patel S, Harmath C et al Comparison of diameter and perimeter methods for tumor volume calculation. Clin. Oncol 19, 551–557 (2001).
   Google Scholar
• Warren KE, Patronas N, Aikin AA, Albert PS, Balls FM. Comparison of one-, two-and three-dimensional measurements of childhood brain tumors. .1. Natl Cancer Inst. 93, 1401–1405 (2001).
   Google Scholar
• Rabinov JD, Lee PL, Barker PG et al. In vivo MRS at 3 tesla predicts recurrent glioma versus radiation effects — initial experience. Radiology225, 871–879 (2002).
   PubMed Web of Science ®Google Scholar
• Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin. Radial. 59, 77–85 (2004).
   Google Scholar
• Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. Am J. Neutvradial 24, 937–941 (2003).
   PubMed Web of Science ®Google Scholar
• Mardor Y, Pfeffer R, Spiegelmann R et al Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. j 011C01. 21, 1094–1100 (2003).
   Google Scholar
• Lev ML, Ozsunar Y, Henson JW et al Glial tumor grading and outcome prediction using dynamic spin-echo mr susceptibility mapping compared to conventional contrast enhanced mri: confounding effect of elevated relative cerebral blood volume of oligodendrogliomas. Am. j Neuroradial 35(2), 214–221 (2004).
   Google Scholar
• Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am. j Neuroradial 21, 891–899 (2000).
   PubMed Web of Science ®Google Scholar